Adult Acute Lymphoblastic Leukemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for relapsed/refractory ALL in the ''Guidelines for the Diagnosis and Treatment of Adult Acute Lymphoblastic Leukemia in China (2016 Edition)''; 2. Aged 18 to 70 years old; 3. No serious organ dysfunction; 4. No history of allergy to the drugs in this group; 5. Each subject (or his legal representative) must sign an informed consent form, indicating that he/she understands the purpose and procedures of the study and is willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with a second tumor; 2. Patients with severe neurological diseases; 3. Uncontrolled or serious infection; 4. The patient or family members request to withdraw from the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complete remission rate;minimal residual disease;overall survival rate;event-free survival; | — |
Countries
China
Contacts
Jiaozuo People's Hospital